Immune cell attack: new hope for tough skin cancers?
Disease control
Recruiting now
This study tests a treatment made from a patient's own immune cells (tumor-infiltrating lymphocytes, or TILs) combined with chemotherapy and interleukin-2 for people with advanced skin cancers (cutaneous squamous cell carcinoma or Merkel cell carcinoma) that have not responded to…
Phase: PHASE2 • Sponsor: Karam Khaddour, MD, MS • Aim: Disease control
Last updated May 17, 2026 02:04 UTC